Noriyasu Haginoya

Introduction: Noriyasu Haginoya, based in Tokyo, Japan, is a prominent inventor known for his innovative contributions in the field of pharmaceuticals. With a total of 12 patents to his name, Haginoya has significantly impacted medical research and drug development.

Latest Patents: Among his latest inventions is a cycloalkane-1,3-diamine derivative, which provides a compound or a pharmaceutically acceptable salt exhibiting an inhibitory action on the interaction between menin and an MLL protein. This invention is represented by a specific formula, where various elements, denoted by R, Ring Q, W, m, and n, are defined in the detailed description. This compound could potentially play a crucial role in therapeutic applications.

Career Highlights: Haginoya's professional journey includes working with notable companies such as Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His tenure at these establishments allowed him to refine his skills and contribute to cutting-edge research in the pharmaceutical industry.

Collaborations: Throughout his career, Haginoya has collaborated with esteemed colleagues, including Tsutomu Nagata and Kenji Yoshikawa. These partnerships have been instrumental in fostering innovation and advancing research efforts within the companies he has served.

Conclusion: Noriyasu Haginoya stands out as an accomplished inventor, significantly contributing to the pharmaceutical landscape in Japan and beyond. With his latest patent focused on groundbreaking medical compounds, he continues to inspire upcoming inventors and researchers in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.